SIG
52
5
DOV
48
2
SWK
53
4
AKAM
50
2
AEE
51
3
NWS
69
5
LEG
16
2
MHK
25
5
SHW
42
5
SLB
41
2
ORCL
49
3
PNC
48
6
FTI
61
5
MMM
35
3
FITB
36
3
BF.B
35
2
COP
36
2
GD
42
4
D
32
10
PEP
33
4
SIG
52
5
DOV
48
2
SWK
53
4
AKAM
50
2
AEE
51
3
NWS
69
5
LEG
16
2
MHK
25
5
SHW
42
5
SLB
41
2
ORCL
49
3
PNC
48
6
FTI
61
5
MMM
35
3
FITB
36
3
BF.B
35
2
COP
36
2
GD
42
4
D
32
10
PEP
33
4
Financhill
Back

Myriad Genetics Quote, Financials, Valuation and Earnings

These 7 Stocks Will Be Magnificent in 2025

Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.
Sell
21

MYGN
Myriad Genetics

Last Price:
$13.35
Seasonality Move:
14.35%

7 Day Trial

ALL ACCESS PASS

$ 7

2025 Gold Forecast: A Perfect Storm for Demand

Discover our Gold Price Outlook for 2025--FREE--here

Myriad Genetics Price Quote

$13.35
-0.01 (1.37%)
(Updated: December 21, 2024 at 5:38 AM ET)

Myriad Genetics Key Stats

Sell
21
Myriad Genetics (MYGN) is a Sell
Day range:
$13.04 - $13.56
52-week range:
$12.87 - $29.30
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.45
P/B ratio:
1.66%
Volume:
3.8M
Avg. volume:
1.1M
1-year change:
-34.25%
Market cap:
$1.2B
Revenue:
$753.2M
EPS:
$-1.3

How Much Does Myriad Genetics Make?

Data Unavailable

Is Myriad Genetics Growing As A Company?

Data Unavailable

Myriad Genetics Stock Price Performance

  • Did Myriad Genetics Stock Go Up Last Month?
    Myriad Genetics share price went down by -12.68% last month
  • Did MYGN's Share Price Rise Over The Last Year?
    MYGN share price fell by -34.25% over the past 1 year

What Is Myriad Genetics 52-Week High & Low?

Myriad Genetics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Myriad Genetics?

Data Unavailable

Is Myriad Genetics Cash Flow Positive?

Data Unavailable

Myriad Genetics Return On Invested Capital

Data Unavailable

Myriad Genetics Earnings Date & Stock Price

Myriad Genetics Competitors

  • Who Are Myriad Genetics's Competitors?
    Below is a list of companies who compete with Myriad Genetics or are related in some way:
    • Boston Scientific Corp (BSX)
    • Perspective Therapeutics Inc (CATX)
    • Globus Medical Inc (GMED)
    • Haemonetics Corp (HAE)
    • ResMed Inc (RMD)

Myriad Genetics Dividend Yield

Data Unavailable

Myriad Genetics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 211.04%
Revenue: 11.15% 1.19%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 6
Sell Recommendations: 0
Price Target: 24.08
Upside from Last Price: 80.26%

Major Shareholders

Data Unavailable